Clinicopathological features and prognostic significance of HER2-low status in breast carcinoma

被引：0
|
作者：
Ilieva-Shipchanova, N. [1 ]
Tashkova, D. [1 ]
Bangieva, E. [1 ]
Miteva, N. [1 ]
机构：
[1] Med Univ Plovdiv, Complex Oncol Ctr Plovdiv, Plovdiv, Bulgaria
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-02-03
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [41] Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
    Meng Yue
    Si Wu
    Chang Liu
    Lijing Cai
    Xinran Wang
    Ying Jia
    Dandan Han
    Yueping Liu
    Breast Cancer Research and Treatment, 2024, 203 : 373 - 381
  • [42] Clinicopathological Features of HER2 Expressing Lobular Carcinoma of Breast
    Sughayer, Maher
    Khader, Majd
    LABORATORY INVESTIGATION, 2023, 103 (03) : S211 - S211
  • [43] The impact of the HER2-low status on conditional survival in patients with breast cancer
    Ma, Teng
    Liu, Changgen
    Ma, Tianyi
    Sun, Xinyi
    Cui, Jian
    Wang, Lulu
    Mao, Yan
    Wang, Haibo
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [44] Clinicopathologic features of early stage HER2-low breast cancer.
    Nashed, Rebecca
    Barger, Hannah
    Fishman, Brooke Taylor
    Schlyer, Dylan A.
    Makani, Neeharika Srivastava
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Clinical, pathological and gene expression features of HER2-low breast cancer
    Schettini, F.
    Chic, N.
    Braso-Maristany, F.
    Pare, L.
    Pascual, T.
    Conte, B.
    Martinez-Saez, O.
    Adamo, B.
    Vidal, M.
    Fernandez-Martinez, A.
    Gonzalez-Farre, B.
    Sanfeliu, E.
    Perrone, G.
    Villagrasa, P.
    Gavila Gregori, J.
    Barrios, C. H.
    Lluch, A.
    Martin Jimenez, M.
    De Placido, S.
    Prat, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S24 - S24
  • [46] HER2-low and gastric cancer: A prognostic biomarker?
    de Mendonca Uchoa, Bruno Cezar
    Pirolli, Rafaela
    Mendes Gomes Siqueira, Luciana Beatriz
    Rocha Moura, Francisca Giselle
    Rondina Correa, Ana Paula
    Batista Rosado, Jose Ecio
    Chinelato, Juliana Rosa
    Felismino, Tiago
    Fonseca Jesus, Victor Hugo
    Spina Donadio, Mauro Daniel
    Melo, Everton
    Cesca, Marcelle Goldner
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Clinical and Epidemiologic Significance of HER2-Low Expression in Breast Cancer in the Pathways Study
    Khoury, Thaer
    Ondracek, Rochelle Payne
    Yao, Song
    Mendocino, Lucas
    Davis, Warren
    Omilian, Angela
    Kwan, Marilyn
    Roh, Janise
    D'Addario, Lia
    Valice, Emily
    Fernandez, Daniel
    Ergas, Isaac
    Ambrosone, Christine
    Kushi, Lawrence
    CANCER RESEARCH, 2024, 84 (09)
  • [48] Association between HER2-low expression and prognostic clinicopathologic factors in breast cancer
    Akkurt, T. Soylemez
    Gurbuz, B. Calim
    Sen, E.
    HISTOPATHOLOGY, 2022, 81 : 22 - 22
  • [49] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [50] Clinicopathological Features and Prognostic Role of HER2 Low in Early Breast Cancer: A real world study
    Kong, Ziqing
    Zhao, Weihong
    CANCER RESEARCH, 2024, 84 (09)
12345